Weight loss jabs such as Wegovy are “lifelong treatments” and most people who stop taking them will lose the effects, a ...
It's not just celebrities and TikTok creators jumping on the weight loss drug hype - more than 500,000 people in the UK are ...
Some people may turn to private healthcare providers in order to get their hands on the weight loss jabs. However, Britons ...
The podcast features Numerator Chief Economist Leo Feler, who talks about the potential impact of GLP-1 drugs like Ozempic ...
We meet some of the first NHS patients, as expert says funding everyone eligible would "bankrupt" the service.
Eli Lilly and other drugmakers are reportedly planning to urge the Trump administration to pause Medicare drug-price ...
Drugs like Ozempic and Wegovy are now costing Connecticut taxpayers about $60 million this year and that figure could rise ...
Nicole Albanese, PharmD, discusses the science behind weight-loss drugs, their potential to treat other addictions as well as ...
The round is one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the booming weight loss market.
More than 90 per cent of weight loss jab users are forced to pay for treatment privately due to their slow roll-out on the ...
Polls provide a useful window into understanding how Americans view their own weight and the recent availability of drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback